| INTRODUC TI ON
Irritable bowel syndrome (IBS) is a chronic recurrent disease characterized by abdominal pain or discomfort associated with defecation, altered bowel habits, and stool form. The pathogenesis of IBS is incompletely understood, but generally thought to involve visceral hypersensitivity 1 and gastrointestinal motor disturbances. 2 IBS is categorized as a functional disorder due to lack of identifiable organic changes. Nevertheless, inflammatory degenerative neuropathy has been observed in full-thickness biopsy specimens from the jejunum of patients with IBS including peri-and intraganglionic infiltration of lymphocytes and neuronal degeneration presenting as cytoplasmic swelling, vacuolization, and shrunken (pyknotic) or ruptured nuclei. 3 The inflammatory degenerative neuropathy could be attributed to cell-mediated immune injury by infiltration of lymphocytes and plasma cells in the myenteric and submucosal plexuses, or humoral responses characterized by circulating antineuronal antibodies. 4 Several autoantibodies have been reported in the sera of patients with IBS, including antibodies against the structural component of bacterial flagellae A4-Fla2 and Fla-X, 5 gonadotropin-releasing hormone (GnRH), 6 and antibodies related to celiac disease. 7 Wood et al. 8 reported that the positive rate of anti-enteric neuronal antibodies (AENA) in IBS was higher than in non-IBS controls, which was detected using the myenteric and submucosal plexuses of guinea pigs as substrates. Sera from patients with chronic intestinal pseudoobstruction (CIPO), which contained antineuronal antibodies, promoted the autophagy of SH-Sy5Y neuroblastoma cells via the Fas receptor, suggesting that antineuronal antibodies induce neuronal dysfunction by promoting autophagy. 4 An immunohistochemical study in patients with IBS found an increase in intraepithelial CD3 + and CD25 + cells, and 10.4% of the patients fulfilled histological diagnostic criteria for lymphocytic colitis as determined by routine pathological examination. 9 A meta-analysis revealed that mast cells and CD3 + T cells were increased in colonic biopsies from IBS patients compared with controls. 10 B lymphocytes, isolated from the blood of patients with IBS, showed increased activation as demonstrated by increased cell surface expression of IgG and costimulatory molecules CD80 and CD86. 11 Furthermore, patients with IBS with diarrhea (IBS-D) had larger numbers of mucosal B lymphocytes, plasma cells, and IgG + cells as compared with healthy controls. 12 Moreover, serum interleukin 6 (IL-6) and IL-8 were elevated in IBS-D relative to controls, while interferon γ was decreased. 13, 14 Collectively, the evidence suggests immune activation as a factor in IBS-D.
Deleterious effects of antineuronal antibodies in the enteric nervous system (ENS) are mainly known for the paraneoplastic syndrome. 15, 16 Involvement of AENA in IBS, their association with intestinal symptoms, and their involvement in IBS pathophysiology remain poorly understood. In view of this, we tested further the hypothesis that autoimmune ENS neuropathy in patients with IBS results from neuronal cell death induced by AENA.
Aside from myenteric neuronal cultures, we used the human neuroblastoma cell clone SH-Sy5Y as AENA targets. SH-Sy5Y were selected because they proliferate rapidly in culture and are widely accepted as research models for human neurons. 4, 15 We hypothesized that AENA-induced neuronal cell death in the ENS is by autoimmune activation of apoptosis. Apoptosis involves numerous changes including DNA, proteins, and cell surface signals. Common apoptosis-associated proteins include Bax, Bcl-2, and caspase-3 which play important roles in extrinsic apoptotic signal pathways. [17] [18] [19] The terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) test is routinely used to detect apoptotic changes in the nucleus. 20 We aimed to demonstrate the positive rate of sera AENA in patients with IBS using indirect immunofluorescence staining of groups were higher than that of AENA mild positive, negative, HS, and FBS (7.6%±0.8% and 10.7%±1.3% vs 5.0%±0.8%, 3.8%±0.3%, 3.4%±0.2% and, 2.8%±0.2%, P < 0.05).
Conclusions and Inferences:
The AENA obvious positive rate in patients with IBS was higher than HS, and sera with higher levels of AENA promoted neuronal apoptosis.
AENA-mediated neuropathy might exist in a subset of patients with IBS.
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Key Points
• The pathophysiology of myenteric neuronal degeneration in patients with irritable bowel syndrome (IBS) is unclear.
• The anti-enteric neuronal antibody (AENA) obvious positive rate in IBS was higher than in healthy subjects and was higher than patients with slow transit functional constipation and inflammatory bowel disease after eliminating the influence of antinuclear antibodies. Sera with obvious positive AENA from patients with IBS promoted neuronal apoptosis in cultured myenteric neurons of guinea pigs and human SH-Sy5Y cells.
• The apoptosis-promoting effects of AENA might explain the autoimmune pathophysiological changes for a subset of patients with IBS.
monkey small intestinal tissues as substrates, to analyze the correlation of AENA with bowel symptoms, and to investigate the apoptosis-promoting effects of AENA positive sera on neurons.
| MATERIAL S AND ME THODS

| Subjects
All subjects were 18-65 years of age. Consecutive patients with IBS that met Rome III diagnostic and subtype criteria 21 
| Questionnaires
Irritable bowel syndrome symptom questionnaires including demographic data, symptom frequency and severity, as well as psychological and sleeping status, were administrated in a face-to-face manner by well-trained investigators. The symptom score of IBS-D was calculated according to our previous publication. 25 The validated simplified
Chinese version of the IBS-quality of life (IBS-QOL) instrument was completed by patients and transformed to scores according to the instructions. 26 The Hamilton anxiety (HAMA) and Hamilton depression (HAMD) scales were used to evaluate patients' psychological status by specially trained professionals through conversation and observation. 27 
| Tissues
A commercial assay kit, which contained biochip mosaics of monkey small intestine as substrates, was used to detect AENA in human serum. In cell culture tests, neurons were obtained from the myenteric plexus of the small intestine of guinea pigs.
| Detection of serum AENA
Fasting venous blood was collected in serum tubes (4 mL, with coagulant/gel, Gieiner bio-one, Kremsmünster, Austria) on the day of the clinic visit no matter their IBS symptoms onset and centrifuged at 300 × g for 5 minutes. Samples were stored at −80°C until use.
Indirect immunofluorescence was used to detect sera AENA with the assay kit (FA1111-1010-14, Euroimmune, Lübeck, Germany). The kit 
| Human SH-Sy5Y cell culture
The human neuroblastoma cell clone SH-Sy5Y cells, which were ob- at 20× magnification using a fluorescence microscope (apoptosis rate).
We used the equivalent volume of PBS instead of primary antibodies as a negative control for anti-active caspase-3.
Anti-PGP9.5/DAPI/TUNEL triple staining
For TUNEL (Roche, Penzberg, Germany) tests, the same procedures for fixation, blocking, and incubation were used as above but incu- is presented as the ratio of the density of target proteins to β-actin.
| Western blot analysis to detect human SHSy5Y cell apoptosis
| Flow cytometry to detect human SH-Sy5Y cell apoptosis
Human SH-Sy5Y cells cultured in 12-well plates were incubated with different groups of sera. After removing the complete medium and washing three times with PBS, 1 mg mL −1 protease was added for 3 minutes at 37°C. Then, the digestion was terminated with complete medium and washed three times with PBS, and 500 µL binding buffer 
| Statistical analyses
All analyses were performed using 
| RE SULTS
The demographic data of subjects are shown in Table 1 . The average age of patients with IBS was older than SLE, and the percentage of female patients was higher in SLE and RA patients (Table 1) . 
| General data of IBS
| Clinical data of disease controls
In patients with STFC, the average percentage of excluded radiopaque markers at 48 hours in GITT was 20.6%±29.6%, and 57.0%±35.4% markers were present in the sigmoid colon and above.
No patients had dyssynergic defecation by ARM.
Patients with CIPO who complained of intestinal obstruction and diagnosed according to abdominal plain X-ray, abdominal, and pelvic contrast-enhanced CT with enterography, colonoscopy, and barium enema showed no evidence of mechanical intestinal obstruction, and some patients underwent GITT and ARM examinations. Three patients were diagnosed as Hirschsprung's disease, and one underwent total colectomy. Other patients achieved improvement after treatment with enteral nutrition, prokinetics, and laxatives.
Among patients with IBD, the percentages of UC and CD were 77.6% and 22.4%, respectively. The positive rates of antineutrophil cytoplasmic antibody, anti-intestinal goblet cell antibody, and antipancreatic antibody were 51%, 26.5%, and 14.3%, respectively.
The initial symptoms of SLE included rash, fever, and arthralgia.
Patients with RA consulted specialists because of arthralgia and 35% of patients had anticyclic citrullinated peptide. No patients had gastrointestinal involvement.
| Serum AENA positive rate
The AENA positive rate and obvious positive rate in patients with IBS were 76.8% and 43.7%, respectively. There was no significant difference in the AENA positive rate and obvious positive rate between males and females (73.4% vs 81.9%, P = 0.09; 40.1% vs 49.1%, P = 0.13). The AENA obvious positive rate in patients with IBS ≥50 years was higher than that in patients <50 years (54.7% vs 39.9%, P = 0.03). The serum AENA staining intensity of patients with IBS was significantly correlated with age (r = 0.13, P = 0.02). The AENA positive rates in ANA-positive and negative patients with IBS were not significantly different (P > 0.05; Table S1 ).
The AENA positive rate in patients with IBS was higher than that in HS and patients with STFC (P < 0.05, Figure 2A ), but there was no significant difference between patients with IBS and patients with IBD or CIPO. While the AENA obvious positive rate in patients with IBS was higher than that in HS (P < 0.05, Figure 2C ), it was not significantly different to STFC, IBD, or CIPO. The AENA positive rate in ANA negative patients with IBS was higher than that in ANA negative patients with STFC (P < 0.05, Figure 2B ), and the AENA obvious positive rate in ANA negative patients with IBS was also higher than that in ANA negative patients with STFC and IBD ( Figure 2D ; Table S1 ).
| Sensitivity and specificity of AENA to diagnose IBS
The sensitivity and specificity of positive AENA to diagnose IBS were 76.8% and 42.3%, respectively. These values were 76.1% and 49%, respectively, in ANA negative subjects. However, the sensitivity and specificity of obvious positive AENA to diagnose IBS were 43.7% and 74.7%, respectively, and were 42.2% and 85% in ANA negative subjects.
| Correlation between AENA and IBS symptoms
Irritable bowel syndrome patients with obvious positive AENA had an older average age and longer average disease course compared with IBS patients with non-obvious positive AENA, although there were no significant differences in intestinal symptoms, or prevalence of anxiety and depression between the two groups ( Table 2 ). The prevalence of ordinary abdominal pain/discomfort (during non-defecation period), moderate-to-severe predefecation abdominal pain/discomfort, and persistent predefecation ab- The flow cytometry results showed the human SH-Sy5Y cell apoptosis rates in AENA moderate positive and intensive positive IBS groups were significantly higher than in the AENA mild positive, negative IBS, HS, and FBS groups (7.6%±0.8% and 10.7%±1.3% vs 5.0%±0.8%, 3.8%±0.3%, 3.4%±0.2%, 2.8%±0.2%; P < 0.05) and were also higher in the AENA intensive positive IBS group compared with the AENA moderate positive IBS group (P < 0.05). There was no significant difference in the apoptosis rate among the AENA mild positive, negative IBS, HS, and FBS groups (P > 0.05; Figure 6 ).
| D ISCUSS I ON
The current study used indirect immunofluorescence to detect sera AENA in a large number of patients with IBS and controls. In addition to HS, we used patients with intestinal diseases similar to IBS including STFC, CIPO, and IBD as the control groups, as well as those with autoimmune diseases SLE and RA. We found that the AENA positive rate and obvious positive rate in patients with IBS were significantly higher than that in HS. The AENA positive rate in HS was 33%, but the majority were mild positive (26%), and thus, the AENA obvious positive rate was relatively lower (7%). The AENA obvious positive rate in IBS patients with negative ANA was also higher than that in STFC and IBD patients with negative ANA.
Sera-positive AENA in patients with IBS was associated with clinical symptoms and sera with moderate and intensive positive AENA from patients with IBS promoted myenteric neuron and SH-Sy5Y cell apoptosis.
We selected commercially available small intestinal tissues of monkeys as substrates to detect AENA to avoid the influence of preparation procedures for the submucosal plexuses. All serum samples were tested for ANA, and we only included HS with ANA negative. Antinuclear antibodies target macromolecular components in the cell nucleus included DNA, RNA, and proteins as well as complexes of nucleic acids with proteins. 30 As shown in This inconsistency between studies might be attributed to a relatively small sample size and lack of disease type classification in the previous studies.
Anti-HuD is an antineuronal antibody. Previous studies showed that sera anti-HuD in patients with paraneoplastic syndrome with intestinal dysmotility 13 and antibodies against Caspase-3 is a pivotal mediator of apoptosis because it can cleave numerous proteins. Active caspase-3 consists of 17 and 11 kDa subunits derived from a 32-kDa proenzyme, and it is an important marker of cell apoptosis. 17 In our study, the apoptosis rate detected by anti-active caspase-3 was higher than that of TUNEL, possibly because TUNEL detects cells at a later stage of death compared with active caspase-3. 33 Annexin V binds to phosphatidylserine exposed at the external surface of cells in the early stages of apoptosis, while PI is a nucleic acid dye that penetrates the plasma membrane in the late stage of apoptosis and in necrotic cells. 34 We inflammatory degenerative neuropathy may progress from IBSlike symptoms to CIPO. 41 Inflammatory neuropathy of the ENS leads to neuronal dysfunction, degeneration, and even results in a complete loss of enteric neurons. 42 The secretory and motor functions of the bowel are regulated by a complicated network connected by different neurons (secretory motor neurons and interneurons) through synapses. 43 Enteric neuronal apoptosis and loss of inhibitory motor neurons may result in hypermotility, spasticity, and clinical symptoms because of the predominance of excitatory neurons. [44] [45] [46] We also identified a relationship be- The sensitivity of positive AENA to diagnose IBS was high, but the specificity was poor, especially when compared with disease controls. Studies reported some patients with STFC had sera antineuronal antibodies including antibodies to voltagegated potassium channels and glutamic acid decarboxylase 48 and patients with IBS, STFC, and CIPO had lymphocytic ganglionitis and neuronal degeneration in full-thickness jejuna biopsy specimens. 38 Ileal segments displayed apoptotic neurons in patients with IBD, 49 indicating the above diseases may have a similar pathophysiology.
There were some limitations in our study. It was difficult to ex- 
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